QXO, Inc. Files 8-K Report
Ticker: QXO-PB · Form: 8-K · Filed: Jul 29, 2024 · CIK: 1236275
| Field | Detail |
|---|---|
| Company | Qxo, Inc. (QXO-PB) |
| Form Type | 8-K |
| Filed Date | Jul 29, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, company-update
TL;DR
QXO filed an 8-K, standard SEC update.
AI Summary
On July 29, 2024, QXO, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits. The company, formerly known as SilverSun Technologies, Inc., is incorporated in Delaware and headquartered in Greenwich, Connecticut.
Why It Matters
This 8-K filing indicates that QXO, Inc. is providing updates and submitting financial information to the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not appear to contain any significant new risks or material adverse information.
Key Numbers
- 000-50302 — Commission File Number (Identifies the company's SEC filing record)
- 16-1633636 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- QXO, Inc. (company) — Registrant
- SilverSun Technologies, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Greenwich, Connecticut (location) — Principal executive offices
- July 29, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for QXO, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and to provide 'Financial Statements and Exhibits' as of July 29, 2024.
What was QXO, Inc.'s former name?
QXO, Inc. was formerly known as SilverSun Technologies, Inc., with a name change date of August 3, 2011.
Where are QXO, Inc.'s principal executive offices located?
QXO, Inc.'s principal executive offices are located at Five American Lane, Greenwich, Connecticut, 06831.
In which state is QXO, Inc. incorporated?
QXO, Inc. is incorporated in Delaware.
What is the filing date for this 8-K report?
The filing date for this 8-K report is July 29, 2024.
Filing Stats: 596 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-07-29 17:15:04
Key Financial Figures
- $0.00001 — h registered Common stock, par value $0.00001 per share QXO The Nasdaq Capital Ma
Filing Documents
- tm2420335d5_8k.htm (8-K) — 25KB
- tm2420335d5_ex5-1.htm (EX-5.1) — 15KB
- 0001104659-24-083598.txt ( ) — 212KB
- qxo-20240729.xsd (EX-101.SCH) — 3KB
- qxo-20240729_lab.xml (EX-101.LAB) — 33KB
- qxo-20240729_pre.xml (EX-101.PRE) — 22KB
- tm2420335d5_8k_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On July 29, 2024, QXO, Inc. (the "Company") filed with the Securities and Exchange Commission (the "SEC") a prospectus supplement to the prospectus included in the Company's registration statement on Form S-3ASR (File No. 333-281084), also filed with the SEC on July 29, 2024 (the "Registration Statement"), covering the resale by certain selling securityholders named therein of an aggregate of (i) 789,549,465 shares of the Company's common stock, consisting of (A) 395,331,333 shares of common stock outstanding, (B) 197,109,067 shares of common stock issuable upon the conversion of shares of the Company's Convertible Perpetual Preferred Stock ("Preferred Stock") and (C) 197,109,065 shares of common stock issuable upon the exercise of warrants to purchase common stock (the "Warrants"), (ii) 900,000 shares of Preferred Stock and (iii) 197,109,065 Warrants, and covering the issuance by the Company of up to 261,010,074 shares of common stock issuable upon the exercise of 219,010,074 Warrants and 42,000,000 pre-funded warrants to purchase common stock. A copy of the legal opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP relating to the securities is filed herewith as Exhibit 5.1 and is incorporated herein by reference, and is filed with reference to, and is hereby incorporated by reference into, the Registration Statement.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 5.1 Opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP. 23.1 Consent of Paul, Weiss, Rifkind, Wharton & Garrison LLP (included in Exhibit 5.1). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 29, 2024 QXO, INC. By: /s/ Christopher Signorello Name: Christopher Signorello Title: Chief Legal Officer